Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0033687 (proteinuria)
 24,015 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A nephrotic syndrome was experimentally induced in rats by a single intravenous injection of aminonucleoside of puromycin. Experimental animals were studied 8 days after the injection, at which time they exhibited marked proteinuria and hypoalbuminemia compared with control animals. The experimental animals also exhibited alterations in protein synthesis in liver as evidenced by a marked increase in the rate of albumin synthesis relative to total hepatic protein synthesis, changes in the relative concentrations of several plasma proteins, an increased protein content of plasma, an increased liver weight relative to body weight, and an increased RNA content of liver. Perfused liver preparations derived from nephrotic rats exhibited an increased release of albumin and other secretory proteins compared with control preparations. In contrast, there was no difference in the rate of synthesis of nonexported proteins between the two groups. The elevation in the relative rate of albumin synthesis was accompanied by a relative increase of the same magnitude in albumin mRNA. Furthermore, the relative amounts of several other mRNAs, including those coding for beta-fibrinogen, haptoglobin, metallothionein II, and two unidentified proteins, were increased, whereas the amount of mRNA coding for alpha 1-acid glycoprotein was decreased in livers of nephrotic rats compared to controls. These results indicate that nephrosis leads to marked alterations in the synthesis of albumin and other plasma proteins. Mechanisms responsible for these alterations include changes in the relative abundance of specific mRNAs and an increase in total cellular RNA.
 ...
PMID:Effects of experimentally induced nephrosis on protein synthesis in rat liver. 336 51

We examined whether plasma fibrinogen levels and the beta-fibrinogen gene G(-455)-->A polymorphism were related to microvascular or macrovascular disease in patients (n = 909) with type 1 diabetes enrolled in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/ EDIC). Univariate regression showed that fibrinogen levels were correlated with BMI (r = 0.15; P < 0.0001), HbA(1c) (r = 0.11; P = 0.0014), total cholesterol (r = 0.17; P < 0.0001), and LDL cholesterol (r = 0.16; P < 0.0001) in all patients. In men, but not women, waist-to-hip ratio (r = 0.20; P < 0.0001) and triglycerides (r = 0.13; P = 0.0047) also became powerful predictors of fibrinogen level; in women, but not men, fibrinogen was correlated with both diastolic (r = 0.16; P = 0.0011) and systolic (r = 0.11; P = 0.0241) blood pressure. Fibrinogen was correlated with urinary albumin excretion rates in men (r = 0.13; P = 0.0033), but not in women. In both sexes, however, the development of proteinuria (albumin excretion >300 mg/24 h) was accompanied by 1.5-fold increment in plasma fibrinogen compared with patients with normal excretion or microalbuminuria. In addition, high fibrinogen levels were associated with a lower average ankle-brachial index in women (r = -0.13; P = 0.0075), but not men. Multiple regression analyses demonstrated that plasma fibrinogen was independently correlated with high albumin excretion rate in men, and with low average ankle-brachial index in women. Fibrinogen was not correlated with the severity of retinopathy. Carotid artery intima-medial thickness was not correlated with fibrinogen, and the G(-455)-->A polymorphism in the 5' promoter region of the beta-fibrinogen gene did not influence circulating fibrinogen levels. However, the presence of the more common G(-455) allele was associated with greater intima-medial thickness in the internal carotid artery (ANCOVA P = 0.045). Last, hyperfibrinogenemia in type 1 diabetes is associated with components of the insulin resistance syndrome trait cluster, and the association is influenced by sex.
 ...
PMID:Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort. 1271 2